Publication | Open Access
Impact of Reflex <i>EGFR</i>/<i>ALK</i> Testing on Time to Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer
55
Citations
12
References
2017
Year
Reflex testing of EGFR/ ALK improved the time to optimal systemic therapy and the quality of biomarker testing for patients with advanced nonsq NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1